Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klara Balint

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|July 19, 2014
Immunotherapy for ovarian cancer: recent advances and perspectivesEmese Zsiros, Janos Tanyi, Klara Balint, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Role of vascular leukocytes in ovarian cancer neovascularizationKlara Balint, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Expert Opinion on Biological Therapy|January 3, 2015
Potential approaches for more successful dendritic cell-based immunotherapyCheryl Lai-Lai Chiang, Klara Balint, George Coukos, et al.
Frontiers in Immunology|April 30, 2019
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical ResultsBeatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquie, et al.
Journal of Translational Medicine|June 20, 2013
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancerLana E Kandalaft, Cheryl L Chiang, Janos Tanyi, et al.
Radiation Research|February 8, 2011
Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activationHouping Ni, Klara Balint, Yu Zhou, et al.
Vaccines|January 18, 2020
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell VaccineCaroline Boudousquié, Valérie Boand, Emilie Lingre, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2006
Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1Zhao-Jun Liu, Min Xiao, Klara Balint, et al.
Cancer Research|April 19, 2006
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expressionZhao-Jun Liu, Min Xiao, Klara Balint, et al.
Plos One|June 25, 2014
Ionizing radiation selectively reduces skin regulatory T cells and alters immune functionYu Zhou, Houping Ni, Klara Balint, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|July 19, 2014
Immunotherapy for ovarian cancer: recent advances and perspectivesEmese Zsiros, Janos Tanyi, Klara Balint, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Role of vascular leukocytes in ovarian cancer neovascularizationKlara Balint, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Expert Opinion on Biological Therapy|January 3, 2015
Potential approaches for more successful dendritic cell-based immunotherapyCheryl Lai-Lai Chiang, Klara Balint, George Coukos, et al.
Frontiers in Immunology|April 30, 2019
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical ResultsBeatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquie, et al.
Journal of Translational Medicine|June 20, 2013
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancerLana E Kandalaft, Cheryl L Chiang, Janos Tanyi, et al.
Radiation Research|February 8, 2011
Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activationHouping Ni, Klara Balint, Yu Zhou, et al.
Vaccines|January 18, 2020
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell VaccineCaroline Boudousquié, Valérie Boand, Emilie Lingre, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2006
Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1Zhao-Jun Liu, Min Xiao, Klara Balint, et al.
Cancer Research|April 19, 2006
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expressionZhao-Jun Liu, Min Xiao, Klara Balint, et al.
Plos One|June 25, 2014
Ionizing radiation selectively reduces skin regulatory T cells and alters immune functionYu Zhou, Houping Ni, Klara Balint, et al.
Pageof 2